Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.12
-0.64 (-2.48%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Zymeworks Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 37.13 | 105.97 | 76.3 | 76.01 | 412.48 | 26.68 | |
Revenue Growth | -69.78% | 38.87% | 0.38% | -81.57% | 1446.03% | -31.50% |
Cost of Revenue | 128.71 | 137 | 136.5 | 142.99 | 208.85 | 199.54 |
Gross Profit | -91.58 | -31.04 | -60.2 | -66.98 | 203.64 | -172.86 |
Selling, General & Admin | 63.98 | 61.51 | 61.51 | 70.45 | 73.36 | 42.56 |
Operating Expenses | 63.98 | 61.51 | 61.51 | 70.45 | 73.36 | 42.43 |
Operating Income | -155.56 | -92.55 | -121.7 | -137.42 | 130.28 | -215.29 |
Interest Expense | -8.66 | - | - | - | - | - |
Interest & Investment Income | 12.5 | 13.35 | 19.94 | 19.71 | 3.6 | 1.97 |
Currency Exchange Gain (Loss) | -0.61 | -0.61 | 0.78 | -1.19 | 1.15 | 1.19 |
Other Non Operating Income (Expenses) | 0.94 | 0.05 | -0.22 | 0.29 | -0.04 | -0.01 |
EBT Excluding Unusual Items | -151.39 | -79.75 | -101.2 | -118.61 | 134.98 | -212.15 |
Other Unusual Items | - | - | 1.88 | -0.63 | 0.25 | -0.21 |
Pretax Income | -151.39 | -79.75 | -116.61 | -119.24 | 135.23 | -212.36 |
Income Tax Expense | -1.4 | 1.38 | 6.08 | -0.57 | 10.89 | -0.52 |
Net Income | -149.99 | -81.13 | -122.7 | -118.67 | 124.34 | -211.84 |
Net Income to Common | -149.99 | -81.13 | -122.7 | -118.67 | 124.34 | -211.84 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 75 | 75 | 76 | 69 | 65 | 52 |
Shares Outstanding (Diluted) | 75 | 75 | 76 | 69 | 65 | 52 |
Shares Change | -0.84% | -0.61% | 10.19% | 5.54% | 25.16% | 3.47% |
EPS (Basic) | -2.01 | -1.08 | -1.62 | -1.72 | 1.91 | -4.11 |
EPS (Diluted) | -2.01 | -1.08 | -1.62 | -1.72 | 1.90 | -4.61 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -120.54 | -34.53 | -112.05 | -120.8 | 135.96 | -204.86 |
Free Cash Flow Per Share | -1.61 | -0.46 | -1.48 | -1.75 | 2.08 | -3.93 |
Gross Margin | -246.66% | -29.29% | -78.89% | -88.11% | 49.37% | - |
Operating Margin | -418.99% | -87.34% | -159.50% | -180.79% | 31.58% | -806.94% |
Profit Margin | -404.00% | -76.56% | -160.80% | -156.13% | 30.14% | -794.01% |
Free Cash Flow Margin | -324.68% | -32.58% | -146.85% | -158.92% | 32.96% | -767.82% |
EBITDA | -150.65 | -84.82 | -113.02 | -127.26 | 137.51 | -208.76 |
EBITDA Margin | - | -80.05% | -148.11% | -167.42% | 33.34% | - |
D&A For EBITDA | 4.91 | 7.73 | 8.68 | 10.16 | 7.24 | 6.53 |
EBIT | -155.56 | -92.55 | -121.7 | -137.42 | 130.28 | -215.29 |
EBIT Margin | - | -87.34% | -159.50% | -180.79% | 31.58% | - |
Effective Tax Rate | - | - | - | - | 8.05% | - |